NEW YORK, ACCESSWIRE / February 28, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Carrols Restaurant Group, Inc. ("Carrols" or the "Company") (NYSE: TAST). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/tast.

The investigation concerns whether Carrols and certain of its officers and/or directors have violated federal securities laws.

On February 25, 2020, Carrols issued a press release reporting its financial results for the fourth quarter and full year ended December 29, 2019. In the press release, Daniel T. Accordino, Carrols' chairman and Chief Executive Officer, reported that "comparable restaurant sales growth for our Burger King restaurants was at the low-end of our annual expectations and full year Adjusted EBITDA relative to 2018 levels was adversely affected by several factors, including increases in commodity and labor costs and the excess sales discounts to certain customers over a ten week period last summer." On this news, Carrols' stock price fell sharply, damaging investors.

If you are aware of any facts relating to this investigation, or purchased Carrols shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/tast. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 578140

NEW YORK, NY / ACCESSWIRE / February 28, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

Luckin Coffee Inc. (NASDAQ:LK)
LK Lawsuit on behalf of: investors who purchased November 13, 2019 – January 31, 2020
Lead Plaintiff Deadline: April 13, 2020
Join the action: https://www.zlk.com/pslra-1/luckin-coffee-inc-loss-form?wire=3&prid=5543

Allegations: Luckin Coffee Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (i) certain of Luckin's financial performance metrics, including per-store per-day sales, net selling price per item, advertising expenses, and revenue contribution from "other products" were inflated; (ii) Luckin's financial results thus overstated the Company's financial health and were consequently unreliable; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

To learn more about the Luckin Coffee Inc. class action, contact jlevi@levikorsinsky.com.

Jeld-Wen Holding, Inc. (NYSE:JELD)
JELD Lawsuit on behalf of: investors who purchased January 26, 2017 – October 15, 2018
Lead Plaintiff Deadline: April 20, 2020
Join the action: https://www.zlk.com/pslra-1/jeld-wen-holding-inc-loss-form?wire=3&prid=5543

Allegations: During the class period, Jeld-Wen Holding, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's products, including doors, did not compete against other manufacturers on price, contrary to Jeld-Wen's representations; (2) the market in which the Company sells its doors is not "highly competitive" as the Company claimed; (3) Jeld-Wen's strong margins and anticipated margin growth were not, as the Company claimed, attributed to changes they had made in Jeld-Wen's business operations and strategies; and (4) Jeld-Wen failed to disclose the Company's anti competitive conduct. Because of the foregoing, Defendants' statements about the Company's business, operations and prospects lacked a reasonable basis.

To learn more about the Jeld-Wen Holding, Inc. class action, contact jlevi@levikorsinsky.com.

Tivity Health, Inc. (NASDAQ:TVTY)
TVTY Lawsuit on behalf of: investors who purchased March 8, 2019 – February 19, 2020
Lead Plaintiff Deadline: April 27, 2020
Join the action: https://www.zlk.com/pslra-1/tivity-health-inc-loss-form?wire=3&prid=5543

Allegations: Tivity Health, Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (i) following the Nutrisystem Acquisition, Tivity's Nutrition segment faced significant operational challenges; (ii) the foregoing would foreseeably have a significant impact on Tivity's revenues; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

To learn more about the Tivity Health, Inc. class action, contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 578351

ANN ARBOR, MI / ACCESSWIRE / February 28, 2020 / Amesite, Inc. (the "Company"), an artificial intelligence software company providing fully-managed, customized, online learning ecosystems for the enterprise, announced today its CEO, Dr. Ann Marie Sastry, will appear as a guest, Friday, February 28th, on CNBC's Squawk Alley in a live segment to air during the 11am EST hour. The segment will focus on artificial intelligence training and education needed for hospitals and global health organizations to detect and track the spread of the Coronavirus.

About Amesite, Inc.

Amesite is a high-tech artificial intelligence software company offering a cloud-based platform for learning products to be cost-effectively and conveniently delivered to learners online, in business, higher education and K-12. Amesite uses artificial intelligence technologies to provide customized environments for learners, up-to-the-minute, curated content, and easy-to-manage interfaces for instructors and learners. For more information, visithttps://www.amesite.com.

About CNBC Squawk Alley

"Squawk Alley" is the destination for news regarding tech on CNBC. Airing live from the floor of the New York Stock Exchange, we bring you all things you need to know focusing on the intersection of Wall Street and technology. From prominent names in the Venture Capital world, to executives from tech companies and disrupters that are reshaping how the world operates, you will hear the news from here first. We are the place where stories of innovation and disruption collide with capital markets and the global economy, the show that is on the front lines. For more information, visit https://www.cnbc.com/squawk-alley/

Forward Looking Statements

This communication contains forward-looking statements concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Media Contact:

Matthew Pennacchio
pennacchio@sunshinesachs.com

SOURCE: Amesite, Inc.

ReleaseID: 578350

Top Media and Communications Executive Matt Bird to run global growth strategy for emerging digital News Agency "Equities News"

NEW YORK, NY / ACCESSWIRE / February 28, 2020 / Equities News (Equities.com, Inc.) announced today the company has appointed MattBird as Network President. The decision comes on the heels of the recent acquisition of the Traders Network Show and expansion plans for the growing News Agency and on-demand original content industry. Mr. Bird will lead Equities' growth strategy as it expands from US markets into the global news agency markets – while also helping to develop new content and strategic partnerships.

"We are very pleased to welcome Matt to the Equities team," said Equities News CEO, Dennis Beckert. "Matt is one of the most influential and well-respected corporate strategists and communications executives in the world. He brings very unique insight and qualifications to Equities News (www.equities.com) along with a strong track record of innovation. His experience cultivating emerging growth organizations into large mainstream brands will shape Equities into a new frontier for the online media industry.

Matt Bird, President of Equities News commented; "it's an exciting time, we are well positioned to transition Equities.com into Equities News to compete in the global news agency and original content syndication industry. More importantly, we are focusing on impact, sustainability and economic development, the key factors driving change across the global economy. I look forward to bringing my experience, relationships and abilities to Equities News.

About Matt Bird

Matt Bird has 20+ years' experience as a leader in Enterprise Communications, Media, technology, publisher and network development, public-private partnerships, Corporate strategy and is a pioneer in the online communications industry. Matt Bird is also a proud supporter of the UN SDGs and Vatican-Based Humanity 2.0.

Currently, Matt Bird is the President of Equities News, the Executive Producer and Co-Host of the "Traders Network Show" (an Equities News Original Show). Matt Bird has accreditations for his work supporting economic development, impact, sustainability and public-private partnership initiatives with; United Nations, EU Parliament, UNCTAD, Vatican (Humanity 2.0), US Department of Commerce, World Economic Forum and more.

Recent Career Highlights:

Matt Bird was recently ranked 3rd worldwide by United Nations "Top 10 Most Influential Communications and Media Executives for Impact". While delivering some of the most successful communication activations in United Nations history. Amongst other initiatives, Matt Bird supported the Sustainable Stock Exchange (SSE) initiatives with dozens heads-of-state, UN Secretary Generals and stock exchange CEOs delivering flawless brand integration and execution for United Nations UNCTAD.

In 2019, Matt Bird was appointed to the Humanity 2.0 Advisory Council – a Vatican based non-profit focused on Human Flushing initiatives.

In 2017, Matt Bird was appointed to the Imperative Fund Advisory Council – Impact fund focused lifting communities out of poverty though infrastructure development initiatives.

In 2017, Matt Bird was appointed to the New York Global Leaders Dialogue (NYGLD) Advisory Council – a thought-leadership and think-tank.

In 2016 Mr. Bird was appointed Acting-Director of Public Relations for United Nations SDG Media Zone during the 71st U.N. General Assembly.

Prior to joining Equities News, Matt Bird is founder and Chairman of 1-800-PublicRelations (1800PR), MUNCmedia and held executive roles at ScreamingMedia (Now MarketWatch), BBDO and IGM.

Follow Matt Bird: Equities News Profile | LinkedIn | Instagram | Twitter | Show Profile

About Equities News | Equities.com

Equities News (www.equities.com) is a news agency – a leading producer, aggregator, and provider of full-length video and editorial coverage of financial, economic development, policy, sustainability, and impact events worldwide. The Equities News network reaches more than 40 million households with its original content syndicated across all four major news networks and dozens of financial and business portals, magazines, and newspapers. Equities News operates five news bureaus: New York, Los Angeles, Vatican City, Baku, and Brussels. Equities provides turn-key hosted and monetized business news solutions for publishers worldwide.

Follow Equities News: Equities.com | Instagram |Facebook | LinkedIn | Twitter

*Equities News are proud supporters of the UN SDGs and Humanity 2.0

CONTACTS:

Business and Partnership Inquiries:
Matt Bird
President
Equities News | Equities.com
C: +1 646.401.4499
E: matt@equities.com
Matt Bird LinkedIn

Media Contact:
Nicole Liddy
Communication Coordinator
Equities News | Equities.com
C: +1 848.702.4173
E: nicole.liddy@equities.com

SOURCE: Equities News

ReleaseID: 578345

NEW YORK, NY / ACCESSWIRE / February 28, 2020 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against HP Inc. ("HP" or the Company") (NYSE:HPQ) and certain of its officers, on behalf of shareholders who purchased HP securities between February 23, 2017 to October 3, 2019 inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/hpq.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that material adverse information. Specifically the complaint alleges that: (1) HP falsely highlighted that the four-box model was an accurate, reliable tool to determine demand and revenue in its Supplies business, and reassured investors that, based on the four-box model, HP had a "clear line of sight to supply stabilization"; (2) defendants repeatedly made false and misleading statements to investors about the reliability of its four-box model and the revenue growth of the Supplies business, touting their "continued confidence in the predictive value of the four box model" and stating that its "Supplies revenue is in line with the expectations that we set, and that our 4-box model continues to drive predictability"; and (3) and as a result, HP common stock traded at artificially inflated prices during the Class Period.

If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/hpq or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in HP you have until April 20, 2020 to request that the Court appoint you as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 577177

NEW YORK, NY / ACCESSWIRE / February 28, 2020 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Southwest Airlines Co. ("Southwest" or the Company") (NYSE:LUV) and certain of its officers, on behalf of shareholders who purchased Southwest securities between December 13, 2018 through January 15, 2020, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/luv.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Southwest's operations were non-compliant with government maintenance and safety regulations; (2) the foregoing issues were exacerbated by Southwest's undue influence over FAA officials and, consequently, lax regulatory oversight of the Company's operations; (3) all of the foregoing significantly increased the safety risks to passengers traveling on Southwest flights and heightened governmental scrutiny into the Company; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times.

On January 30, 2020, the Wall Street Journal published an article entitled "Southwest Flew Millions on Jets With Unconfirmed Maintenance Records, Government Report Says." Citing "a government report to be released in coming days," the article reported, among other things, that "Southwest pilots flew more than 17 million passengers on planes with unconfirmed maintenance records over roughly two years, and in 2019 smashed both wingtips of a jet on a runway while repeatedly trying to land amid gale-force winds" and that "FAA managers in the Dallas-area office that supervises Southwest routinely allowed the carrier ‘to fly aircraft with unresolved safety concerns." On this news, Southwest's stock price fell $1.06 per share, or 1.86%, to close at $55.83 per share on January 30, 2020.

If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/luv or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Southwest you have until April 20, 2020 to request that the Court appoint you as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com'

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 577169

NEW YORK, NY / ACCESSWIRE / February 28, 2020 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against JELD-WEN Holding, Inc. ("JELD-WEN" or the Company") (NYSE:JELD) and certain of its officers, on behalf of shareholders who purchased JELD-WEN securities between January 26, 2017 and October 15, 2018, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/jeld.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Jeld-Wen products, including doors, compete against other manufacturers on price, and described the market in which the Company sells its doors as "highly competitive"; and (2) Jeld-Wen's strong margins and anticipated margin growth were attributed to legitimate business factors, such as "making strategic pricing decisions based on an analysis of customer and product level profitability" and increasing its emphasis on "pricing optimization"; (3) these and similar statements made by defendants during the Class Period were false and misleading because defendants knew that Jeld-Wen was engaged in a price-fixing conspiracy with another door manufacturer to artificially increase or maintain prices of interior molded doors; and (4) consequently, Jeld-Wen common stock traded at artificially inflated prices throughout the Class Period.

If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/jeld or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in JELD-WEN you have until April 20, 2020 to request that the Court appoint you as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 577204

PRINCETON, NJ / ACCESSWIRE / February 28, 2020 / Sonnet BioTherapeutics, Inc., a company developing innovative targeted biologic drugs with enhanced single- or bi-specific mechanisms, announced today that Jay Cross, Chief Financial Officer, will present a corporate overview at the 40th Annual Cowen Health Care Conference in Boston, MA held March 2-4, 2020.

Sonnet BioTherapeutics Presentation Details:

40th Annual Cowen Health Care Conference
Date: Wednesday, March 4, 2020
Presentation Time: 8:30am ET

About Sonnet BioTherapeutics, Inc.

Founded in 2011, Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single- or bi-specific action. Known as FHAB™ (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and "hitch-hikes" on human serum albumin (HSA) for transport to target tissues. FHAB™ is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes, including cytokines, peptides, antibodies and vaccines.

Sonnet Biotherapeutics Investor Contact

Alan Lada
Solebury Trout
617-221-8006
alada@soleburytrout.com

SOURCE: Sonnet BioTherapeutics, Inc.

ReleaseID: 578349

ROCKVILLE, MD / ACCESSWIRE / February 28, 2020 / The American Kidney Fund (AKF) applauds Senators Bill Cassidy (R-LA) and Dick Durbin (D-IL) for their leadership in introducing companion legislation to the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019. When passed, S. 3353 and H.R. 5534 will extend Medicare coverage of immunosuppressive drugs for kidney transplant patients for the life of the transplant for Medicare patients under age 65.

"This bill is a game-changer for those Americans who are fortunate enough to receive a kidney transplant but who stand to lose Medicare coverage for the immunosuppressive drugs after three years," said LaVarne A. Burton, AKF president and CEO of AKF, the nation's leading nonprofit working on behalf of the 37 million Americans living with kidney disease. "Transplant patients must take these drugs for as long as their transplanted kidney is functioning, and this bill will help ensure that no one has to stop taking these drugs-and go back on dialysis-because they cannot afford them."

Most Americans with end-stage renal disease (ESRD, or kidney failure) under age 65 become eligible for Medicare, but they lose eligibility three years after receiving a kidney transplant. Those who do not have other insurance coverage to cover their immunosuppressive drugs often cannot afford the cost, which is typically thousands of dollars each month. If they stop taking immunosuppressive drugs, their transplanted kidney will fail, and they will again need dialysis to stay alive, at which point they again become eligible for Medicare.

"The cost of paying for immunosuppressive drugs is a fraction of the cost of paying for dialysis," Burton noted. "This bill is not only the right thing to do for patients, but it is also fiscally responsible legislation that will save American taxpayers money over the long term. We urge both the Senate and the House of Representatives to quickly move ahead with this common-sense legislation that saves lives and money."

About Us

The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation's leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease-from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. AKF is one of the nation's top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator and the Platinum Seal of Transparency from GuideStar.

For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn.

Contacts: 

Alice Andors
Senior Director of Communications
Work: 240-292-7053
Mobile: 703-609-6085
aandors@kidneyfund.org
KidneyFund.org
11921 Rockville Pike, Suite 300

SOURCE: American Kidney Fund

ReleaseID: 578343

NEW YORK, NY / ACCESSWIRE / February 28, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Forescout Technologies, Inc. (NASDAQ:FSCT)

Investors Affected : February 7, 2019 – October 9, 2019

A class action has commenced on behalf of certain shareholders in Forescout Technologies, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Forescout was experiencing significant volatility with respect to large deals and issues related to the timing and execution of deals in the Company's pipeline, especially in Europe, the Middle East, and Africa; (ii) the foregoing was reasonably likely to have a material negative impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/forescout-technologies-inc-loss-submission-form/?id=5542&from=1

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA)

Investors Affected : May 8, 2019 – January 9, 2020

A class action has commenced on behalf of certain shareholders in Portola Pharmaceuticals, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Portola's internal control over financial reporting regarding reserve for product returns was not effective; (2) Portola was shipping longer-dated product with 36-month shelf life; (3) Portola had not established adequate reserve for returns of prior shipments of short-dated product; (4) as a result, Portola was reasonably likely to need to "catch up" on accounting for return reserves; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/portola-pharmaceuticals-inc-loss-submission-form/?id=5542&from=1

Westpac Banking Corporation (NYSE:WBK)

Investors Affected : November 11, 2015 – November 19, 2019

A class action has commenced on behalf of certain shareholders in Westpac Banking Corporation. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) contrary to Australian law, the Company failed to report over 19.5 million international funds transfer instructions to the Australian Transaction Reports and Analysis Centre ("AUSTRAC"); (2) the Company did not appropriately monitor and assess the ongoing money laundering and terrorism financing risks associated with movement of money into and out of Australia; (3) the Westpac did not pass on requisite information about the source of funds to other banks in the transfer chain; (4) despite being aware of the heightened risks, the Company did not carry out appropriate due diligence on transactions in South East Asia and the Philippines that had known financial indicators relating to child exploitation risks; (5) the Company's Anti-Money Laundering and Counter-Terrorism Financing Policy Program was inadequate to identify, mitigate and manage money laundering and terrorism financing risks; and (6) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/westpac-banking-corporation-loss-submission-form/?id=5542&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 578348